RETREATMENT OF HEPATITIS C VIRUS-INFECTED PATIENTS WHO FAILED GLECAPREVIR/PIBRENTASVIR

被引：0
|
作者：
Weilert, Frank [1 ]
Tang, Hong [2 ,3 ]
Yao, Betty [4 ]
Lin, Minghua [5 ]
Mao, Qing [6 ]
Skoien, Richard [7 ]
Paik, Seung Woon [8 ]
Xie, Wen [9 ]
Tripathi, Rakesh [4 ]
Zhang, Zhenzhen [4 ]
Burroughs, Margaret [4 ]
Gane, Edward J. [10 ]
机构：
[1] Waikato Hosp, Hamilton, New Zealand
[2] West China Hosp, Ctr Infect Dis, Chengdu, Peoples R China
[3] Sichuan Univ, Chengdu, Peoples R China
[4] Abbvie Inc, N Chicago, IL USA
[5] Fujian Med Univ, Mengchao Hepatobiliary Hosp, Fuzhou, Peoples R China
[6] AMU, Hosp 1, Chongqing, Peoples R China
[7] Royal Brisbane & Womens Hosp, Dept Gastroenterol & Hepatol, Brisbane, Qld, Australia
[8] Sungkyunkwan Univ, Dept Med, Samsung Med Ctr, Sch Med, Seoul, South Korea
[9] Capital Med Univ, Beijing Tan Hosp, Beijing, Peoples R China
[10] Univ Auckland, New Zealand Liver Transplant Unit, Auckland, New Zealand
来源：
HEPATOLOGY | 2021年 / 74卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
982
引用
收藏
页码：601A / 601A
页数：1
相关论文
共 50 条
  • [1] Retreatment of patients who failed glecaprevir/pibrentasvir treatment for hepatitis C virus infection
    Wyles, D.
    Weiland, O.
    Yao, B.
    Reindollar, R.
    Weilert, F.
    Dufour, JF.
    Gordon, S. C.
    Poordad, F.
    Stoehr, A.
    Brown, A.
    Mauss, S.
    Samanta, S.
    Pilot-Matias, T.
    Jr, L. R.
    Trinh, R.
    [J]. JOURNAL OF HEPATOLOGY, 2018, 68 : S23 - S24
  • [2] Retreatment of patients who failed glecaprevir/pibrentasvir treatment for hepatitis C virus infection
    Wyles, David
    Weiland, Ola
    Yao, Betty
    Weilert, Frank
    Dufour, Jean-Francois
    Gordon, Stuart C.
    Stoehr, Albrecht
    Brown, Ashley
    Mauss, Stefan
    Zhang, Zhenzhen
    Pilot-Matias, Tami
    Rodrigues, Lino, Jr.
    Mensa, Federico J.
    Poordad, Fred
    [J]. JOURNAL OF HEPATOLOGY, 2019, 70 (05) : 1019 - 1023
  • [3] Retreatment of patients who failed glecaprevir/pibrentasvir treatment for hepatitis C virus infection
    Wyles, David
    Weiland, Ola
    Yao, Betty
    Reindollar, Robert
    Weilert, Frank
    Dufour, Jean-Francois
    Gordon, Stuart
    Poordad, Fred
    Stoehr, Albrecht
    Brown, Ashley
    Mauss, Stefan
    Samanta, Suvajit
    Pilot-Matias, Tami
    Rodrigues, Lino, Jr.
    Trinh, Roger
    [J]. SWISS MEDICAL WEEKLY, 2018, 148 : 25S - 25S
  • [4] RETREATMENT OF PATIENTS WHO FAILED GLECAPREVIR/PIBRENTASVIR TREATMENT FOR HEPATITIS C VIRUS INFECTION
    Wyles, David L.
    Weiland, Ola
    Yao, Betty B.
    Reindollar, Robert
    Weilert, Frank
    Dufour, Jean-Francois
    Gordon, Stuart C.
    Poordad, Fred
    Stoehr, Albrecht
    Brown, Ashley S.
    Mauss, Stefan
    Samanta, Suvajit
    Pilot-Matias, Tami
    Rodrigues, Lino
    Trinh, Roger N.
    [J]. GASTROENTEROLOGY, 2018, 154 (06) : S1082 - S1082
  • [5] Glecaprevir and pibrentasvir combination therapy for hepatitis C virus-infected Japanese patients on hemodialysis
    Tanaka Y.
    Masaki T.
    Uojima H.
    Ohtake T.
    Fujikawa T.
    Yamanouchi Y.
    Wada N.
    Kubota K.
    Hidaka H.
    Nakazawa T.
    Shibuya A.
    Aoyama T.
    Sung J.H.
    Kako M.
    Kobayashi S.
    Takeuchi Y.
    Koizumi W.
    [J]. Renal Replacement Therapy, 4 (1)
  • [6] Glecaprevir and Pibrentasvir Exposures in Hepatitis C Virus-Infected Subjects in Phase 2 and 3 Studies
    Lin, Chih-Wei
    Eckert, Doerthe
    Mensing, Sven
    Liu, Wei
    [J]. HEPATOLOGY, 2017, 66 : 641A - 641A
  • [7] Efficacy and safety of glecaprevir/pibrentasvir as retreatment therapy for patients with genotype 2 chronic hepatitis C who failed prior sofosbuvir plus ribavirin regimen
    Kusakabe, Atsunori
    Kurosaki, Masayuki
    Itakura, Jun
    Joko, Kouji
    Akahane, Takehiro
    Tsuji, Keiji
    Kobashi, Haruhiko
    Sohda, Tetsuro
    Kimura, Hiroyuki
    Narita, Ryouichi
    Furuta, Koichirou
    Izumi, Namiki
    [J]. HEPATOLOGY RESEARCH, 2019, 49 (10) : 1121 - 1126
  • [8] SOFOSBUVIR/VELPATASVIR VS GLECAPREVIR/PIBRENTASVIR IN GENOTYPE 3 HEPATITIS C VIRUS INFECTED PATIENTS
    Margusino-Framinan, L.
    Cid-Silva, P.
    Rotea-Salvo, S.
    Mena-de-Cea, A.
    Delgado, M.
    Vazquez-Rodriguez, P.
    Sanclaudio-Luhia, I
    Suarez-Lopez, F.
    Herranz, I
    Castro-Iglesias, A.
    [J]. VALUE IN HEALTH, 2019, 22 : S640 - S640
  • [9] Successful retreatment with 12 weeks of glecaprevir and pibrentasvir for a genotype 2a HCV-infected hemodialysis patient who failed to respond to 8 weeks of prior glecaprevir and pibrentasvir therapy
    Kazuki Ohya
    Michio Imamura
    Mitsutaka Osawa
    Yuji Teraoka
    Kei Morio
    Hatsue Fujino
    Atsushi Ono
    Takashi Nakahara
    Eisuke Murakami
    Masami Yamauchi
    Tomokazu Kawaoka
    Akira Hiramatsu
    Masataka Tsuge
    Hiroshi Aikata
    Clair Nelson Hayes
    Kazuaki Chayama
    [J]. Clinical Journal of Gastroenterology, 2020, 13 : 267 - 270
  • [10] Outcome of liver transplantation in hepatitis C virus-infected patients who received hepatitis C virus-infected grafts
    Vargas, HE
    Laskus, T
    Wang, LF
    Lee, R
    Radkowski, M
    Dodson, F
    Fung, JJ
    Rakela, J
    [J]. GASTROENTEROLOGY, 1999, 117 (01) : 149 - 153
12345